Pfizer Corporation

Pfizer Products Inc.

Cory Michael Stiff

Douglas Scott Johnson

Chakrapani Subramanyam

Christopher John O'Donnell

Michael Eric Green

Martin Youngjin Pettersson

Tuan Phong Tran

Christopher William Am Ende

Patrick Robert Verhoest

Nandini Chaturbhai Patel

Antonia Friederike Stepan

Gregory Wayne Kauffman

Christopher John O'donnell

Benjamin Adam Fish

Patrick Bradley Mullins

Thayalan Navaratnam

Scott E Lazerwith

Lijuan Jane Wang

Suzanne Ross Kesten

Marvin Jay Meyers

Lorraine Kathleen Fay

Mark Anthony Morris

Scott Edward Lazerwith

Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders

Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I as defined herein. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

Bicyclic pyridinones

The present invention relates to compounds of Formula (I) or a pharmaceutically acceptable salt thereof; processes for the preparation of the compounds; intermediates used in the preparation of the compounds; compositions containing the compounds; and uses of the compounds in treating diseases or conditions associated with fatty acid amide hydrolase (FAAH) activity.

Biaryl ether urea compounds

Growing community of inventors

Salem, CT, United States of America

Cory Michael Stiff